Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Liping Yu

Concepts (257)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Autoantibodies
55
2026
1513
5.490
 Why?
Diabetes Mellitus, Type 1
59
2026
3952
3.540
 Why?
Luminescent Measurements
7
2021
75
2.810
 Why?
Celiac Disease
8
2023
314
2.160
 Why?
Islets of Langerhans
23
2026
853
2.060
 Why?
Glutamate Decarboxylase
15
2022
166
1.820
 Why?
Electrochemical Techniques
4
2021
55
1.650
 Why?
High-Throughput Screening Assays
3
2020
178
1.480
 Why?
Zinc Transporter 8
11
2026
70
1.370
 Why?
Autoimmune Diseases
5
2020
471
1.270
 Why?
Transglutaminases
6
2023
159
1.200
 Why?
Mass Screening
11
2021
1375
1.150
 Why?
Insulin Antibodies
10
2016
103
1.130
 Why?
Prediabetic State
6
2015
251
1.060
 Why?
Cation Transport Proteins
8
2013
120
1.040
 Why?
Receptor-Like Protein Tyrosine Phosphatases, Class 8
6
2016
54
0.920
 Why?
Insulin
20
2021
2526
0.860
 Why?
Proinsulin
4
2016
54
0.850
 Why?
Sensitivity and Specificity
14
2022
2017
0.840
 Why?
Diagnostic Techniques, Endocrine
3
2019
15
0.650
 Why?
Autoantigens
7
2021
429
0.620
 Why?
Antibodies, Viral
2
2023
687
0.520
 Why?
Autoimmunity
12
2023
935
0.500
 Why?
Child, Preschool
25
2023
12016
0.440
 Why?
Child
33
2026
22979
0.430
 Why?
Biomarkers
7
2022
4351
0.410
 Why?
Glucose Intolerance
1
2015
142
0.400
 Why?
Adolescent
29
2026
22825
0.380
 Why?
Infant
19
2023
10194
0.380
 Why?
Humans
64
2026
147293
0.360
 Why?
Luminescence
4
2016
37
0.350
 Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
95
0.330
 Why?
Peptide Fragments
8
2016
698
0.300
 Why?
Male
31
2026
73950
0.290
 Why?
Young Adult
14
2026
14437
0.290
 Why?
Female
35
2026
80076
0.290
 Why?
Immunologic Factors
1
2011
261
0.290
 Why?
Protein Precursors
3
2021
136
0.280
 Why?
Diabetes Mellitus, Type 2
3
2022
2627
0.280
 Why?
Radioimmunoassay
4
2016
165
0.280
 Why?
Radioligand Assay
2
2009
36
0.270
 Why?
Quality Improvement
1
2017
1321
0.270
 Why?
Adult
19
2026
41405
0.260
 Why?
Antibodies, Antinuclear
1
2007
62
0.250
 Why?
Reagent Kits, Diagnostic
1
2007
33
0.250
 Why?
Disease Progression
9
2019
2890
0.230
 Why?
Risk Factors
10
2021
11017
0.230
 Why?
Nephrotic Syndrome
1
2026
43
0.230
 Why?
Seroepidemiologic Studies
3
2023
172
0.220
 Why?
Insulin-Secreting Cells
3
2019
393
0.220
 Why?
Podocytes
1
2026
80
0.220
 Why?
Addison Disease
3
2012
38
0.220
 Why?
Middle Aged
13
2026
36821
0.210
 Why?
Lupus Erythematosus, Systemic
1
2007
242
0.210
 Why?
Enzyme-Linked Immunosorbent Assay
5
2011
849
0.200
 Why?
CD4-Positive T-Lymphocytes
4
2021
1162
0.200
 Why?
Membrane Glycoproteins
1
2026
499
0.190
 Why?
Case-Control Studies
3
2021
3660
0.190
 Why?
Isoenzymes
2
2004
296
0.180
 Why?
Disease Susceptibility
2
2020
347
0.180
 Why?
Electrochemistry
1
2021
70
0.170
 Why?
Interleukin 1 Receptor Antagonist Protein
1
2022
253
0.170
 Why?
Genotype
9
2016
1875
0.170
 Why?
China
1
2021
278
0.160
 Why?
Polymorphism, Genetic
4
2017
615
0.160
 Why?
Predictive Value of Tests
6
2015
2133
0.160
 Why?
DNA
1
2007
1444
0.160
 Why?
GTP-Binding Proteins
1
2021
153
0.160
 Why?
Spike Glycoprotein, Coronavirus
1
2021
129
0.150
 Why?
Steroid 21-Hydroxylase
3
2012
27
0.150
 Why?
Health Fairs
1
2019
10
0.150
 Why?
Follow-Up Studies
6
2021
5476
0.150
 Why?
Endothelial Cells
1
2026
886
0.150
 Why?
Risk Assessment
3
2020
3784
0.140
 Why?
Phosphoproteins
1
2021
337
0.140
 Why?
Colorado
4
2023
4591
0.140
 Why?
Prognosis
5
2021
4383
0.140
 Why?
Prevalence
3
2023
2889
0.140
 Why?
Epitopes
4
2021
475
0.130
 Why?
Polyendocrinopathies, Autoimmune
1
2017
18
0.130
 Why?
Antibody Specificity
4
2011
180
0.130
 Why?
Receptors, Antigen, T-Cell
2
2023
679
0.130
 Why?
Cohort Studies
3
2021
6099
0.130
 Why?
Population Surveillance
1
2020
486
0.130
 Why?
Mice, Inbred NOD
8
2008
616
0.120
 Why?
Disease Management
1
2020
654
0.120
 Why?
Health Care Costs
1
2020
428
0.120
 Why?
Age of Onset
4
2026
568
0.120
 Why?
HLA-DQ Antigens
5
2016
174
0.120
 Why?
T-Lymphocytes
5
2023
2017
0.110
 Why?
Aged
6
2026
26514
0.110
 Why?
Risk
2
2019
927
0.110
 Why?
Incidence
1
2021
2954
0.110
 Why?
Hematopoietic Stem Cell Transplantation
1
2020
703
0.110
 Why?
Transcription Factors
2
2017
1747
0.100
 Why?
Protein Tyrosine Phosphatases
3
2004
167
0.100
 Why?
Poly I-C
2
2004
58
0.100
 Why?
Biopsy
1
2016
1093
0.100
 Why?
Reproducibility of Results
2
2019
3448
0.090
 Why?
Prospective Studies
6
2023
8164
0.090
 Why?
Histocompatibility Antigens Class I
3
2009
207
0.090
 Why?
HLA-DR Antigens
4
2016
220
0.090
 Why?
Iodine Radioisotopes
1
2011
138
0.080
 Why?
Pedigree
3
2017
522
0.080
 Why?
Mice
15
2026
18491
0.080
 Why?
Glucose Tolerance Test
1
2012
361
0.080
 Why?
Rituximab
1
2011
211
0.080
 Why?
HLA-DR4 Antigen
3
2011
74
0.080
 Why?
HLA-DR3 Antigen
3
2011
76
0.080
 Why?
Drug Administration Schedule
1
2011
789
0.070
 Why?
Animals
16
2026
38410
0.070
 Why?
Laboratories
1
2009
111
0.070
 Why?
Radioimmunoprecipitation Assay
1
2007
6
0.060
 Why?
Antibody Formation
1
2008
288
0.060
 Why?
Longitudinal Studies
3
2021
3027
0.060
 Why?
Interferon-alpha
2
2009
201
0.060
 Why?
Histocompatibility Antigens
1
2008
102
0.060
 Why?
Diagnosis, Differential
1
2011
1518
0.060
 Why?
Family
1
2012
690
0.060
 Why?
Peptides
2
2023
1003
0.060
 Why?
Recombinant Fusion Proteins
1
2009
669
0.060
 Why?
Membrane Proteins
2
2004
1171
0.060
 Why?
Double-Blind Method
1
2011
2080
0.060
 Why?
CD4 Antigens
2
2003
137
0.060
 Why?
Integrin beta1
1
2026
33
0.060
 Why?
Proteinuria
1
2026
104
0.060
 Why?
C-Peptide
2
2016
191
0.060
 Why?
Receptors, Complement
1
2026
123
0.060
 Why?
Kidney Glomerulus
1
2026
125
0.050
 Why?
Transforming Growth Factor beta1
1
2026
177
0.050
 Why?
Anaphylaxis
2
2004
105
0.050
 Why?
Antibodies, Heterophile
1
2004
12
0.050
 Why?
Twins, Dizygotic
1
2004
108
0.050
 Why?
Models, Biological
1
2011
1772
0.050
 Why?
Mice, Knockout
3
2026
3153
0.050
 Why?
Endocrine System Diseases
1
2004
35
0.050
 Why?
Mice, Inbred BALB C
5
2004
1266
0.050
 Why?
Immunity, Mucosal
1
2004
98
0.050
 Why?
Siblings
1
2004
197
0.050
 Why?
Glycolipids
1
2004
53
0.050
 Why?
Doxorubicin
1
2026
411
0.050
 Why?
Remission Induction
1
2004
310
0.050
 Why?
Immunoglobulin E
2
2021
316
0.050
 Why?
Genetic Testing
1
2005
493
0.050
 Why?
Osteopontin
1
2022
37
0.050
 Why?
Fetal Blood
1
2004
327
0.040
 Why?
Epitopes, B-Lymphocyte
1
2021
20
0.040
 Why?
Diagnostic Techniques, Radioisotope
1
2021
9
0.040
 Why?
Seroconversion
1
2021
48
0.040
 Why?
Immunoglobulin D
1
2021
29
0.040
 Why?
Serologic Tests
1
2021
54
0.040
 Why?
Canada
1
2002
435
0.040
 Why?
Diabetes Mellitus, Experimental
1
2002
199
0.040
 Why?
Polymorphism, Single Nucleotide
1
2008
2223
0.040
 Why?
Multicenter Studies as Topic
1
2002
417
0.040
 Why?
Asymptomatic Diseases
1
2021
104
0.040
 Why?
Immunoglobulin G
2
2021
901
0.040
 Why?
Quality-Adjusted Life Years
1
2020
126
0.040
 Why?
Immunoglobulin M
1
2021
267
0.040
 Why?
Immunoglobulin A
1
2021
214
0.040
 Why?
Blood Specimen Collection
1
2019
37
0.040
 Why?
Costs and Cost Analysis
1
2020
221
0.040
 Why?
Infant, Newborn
4
2005
6543
0.040
 Why?
Age Factors
2
2004
3372
0.040
 Why?
Early Diagnosis
1
2020
254
0.040
 Why?
Methylation
1
2019
242
0.040
 Why?
Adrenocorticotropic Hormone
2
2012
147
0.030
 Why?
Proportional Hazards Models
2
2016
1344
0.030
 Why?
Cell Death
1
2019
383
0.030
 Why?
Loss of Function Mutation
1
2017
46
0.030
 Why?
Alleles
3
2009
909
0.030
 Why?
Tissue Donors
1
2021
427
0.030
 Why?
Community Health Services
1
2019
231
0.030
 Why?
Diabetic Ketoacidosis
1
2020
212
0.030
 Why?
Cost-Benefit Analysis
1
2020
653
0.030
 Why?
Clinical Trials as Topic
1
2002
1072
0.030
 Why?
Mice, Transgenic
3
2008
2197
0.030
 Why?
Hydrocortisone
2
2012
300
0.030
 Why?
Phenotype
2
2021
3216
0.030
 Why?
HLA-DQ beta-Chains
2
2009
58
0.030
 Why?
Antibodies, Monoclonal
1
2003
1514
0.030
 Why?
Oligonucleotide Array Sequence Analysis
2
2008
751
0.030
 Why?
Cross-Sectional Studies
2
2023
6011
0.030
 Why?
Antibody Affinity
1
2016
60
0.030
 Why?
Time Factors
3
2016
7173
0.030
 Why?
Protein Domains
1
2017
313
0.030
 Why?
Polymerase Chain Reaction
2
2009
1046
0.030
 Why?
Organ Specificity
2
2007
310
0.030
 Why?
Genome-Wide Association Study
1
2022
1496
0.030
 Why?
Proteomics
1
2022
1203
0.030
 Why?
HEK293 Cells
1
2017
745
0.030
 Why?
Blood Glucose
3
2016
2359
0.030
 Why?
Injections, Subcutaneous
2
2004
170
0.030
 Why?
Adoptive Transfer
2
2005
200
0.030
 Why?
Mice, SCID
2
2005
369
0.020
 Why?
Protein Tyrosine Phosphatase, Non-Receptor Type 1
2
2004
44
0.020
 Why?
Multivariate Analysis
1
2016
1550
0.020
 Why?
Renin
1
2012
33
0.020
 Why?
Spleen
2
2005
509
0.020
 Why?
Signal Transduction
1
2026
5272
0.020
 Why?
Administration, Oral
2
2004
874
0.020
 Why?
Immunization
2
2004
375
0.020
 Why?
Enzyme-Linked Immunospot Assay
1
2011
40
0.020
 Why?
Feasibility Studies
1
2015
1147
0.020
 Why?
Hypoglycemic Agents
1
2020
1415
0.020
 Why?
Graves Disease
1
2009
32
0.020
 Why?
Homozygote
1
2009
199
0.020
 Why?
HLA-DRB1 Chains
1
2009
110
0.020
 Why?
Microsatellite Repeats
1
2009
159
0.020
 Why?
International Cooperation
1
2009
198
0.020
 Why?
Retrospective Studies
1
2026
17560
0.020
 Why?
Interferon-gamma
1
2011
786
0.020
 Why?
Metabolic Networks and Pathways
1
2008
175
0.020
 Why?
Pediatrics
1
2015
1139
0.020
 Why?
ROC Curve
1
2009
626
0.020
 Why?
Age Distribution
1
2007
406
0.020
 Why?
Rats
2
2004
5613
0.010
 Why?
Thyroglobulin
1
2005
29
0.010
 Why?
Iodide Peroxidase
1
2005
35
0.010
 Why?
Integrin alpha Chains
1
2004
22
0.010
 Why?
Family Health
1
2005
195
0.010
 Why?
Histocompatibility Testing
1
2004
123
0.010
 Why?
B7-1 Antigen
1
2004
55
0.010
 Why?
False Positive Reactions
1
2004
124
0.010
 Why?
Endocrine System
1
2004
22
0.010
 Why?
United States
1
2002
16313
0.010
 Why?
Single-Blind Method
1
2004
319
0.010
 Why?
Disease Models, Animal
2
2004
4604
0.010
 Why?
HLA Antigens
1
2005
245
0.010
 Why?
Species Specificity
1
2004
547
0.010
 Why?
T-Box Domain Proteins
1
2003
106
0.010
 Why?
Cyclophosphamide
1
2003
277
0.010
 Why?
Enkephalins
1
2002
21
0.010
 Why?
Pyridinium Compounds
1
2002
31
0.010
 Why?
Delivery, Obstetric
1
2004
164
0.010
 Why?
Reference Values
1
2004
800
0.010
 Why?
CD8 Antigens
1
2002
70
0.010
 Why?
HLA-A Antigens
1
2002
52
0.010
 Why?
Mice, Inbred C57BL
2
2004
6041
0.010
 Why?
Models, Immunological
1
2002
99
0.010
 Why?
Gene Expression Profiling
1
2008
1794
0.010
 Why?
Chronic Disease
1
2008
1844
0.010
 Why?
Regression Analysis
1
2004
1003
0.010
 Why?
Antibodies
1
2003
398
0.010
 Why?
Antigens, CD
1
2004
562
0.010
 Why?
Major Histocompatibility Complex
1
2002
234
0.010
 Why?
Glucagon
1
2002
114
0.010
 Why?
Cells, Cultured
1
2008
4169
0.010
 Why?
Histocompatibility Antigens Class II
1
2002
364
0.010
 Why?
Survival Analysis
1
2003
1386
0.010
 Why?
Amino Acid Sequence
1
2004
2134
0.010
 Why?
Genetic Predisposition to Disease
1
2008
2458
0.010
 Why?
Proteins
1
2004
1024
0.010
 Why?
Immunity, Innate
1
2004
840
0.010
 Why?
Immunohistochemistry
1
2002
1730
0.010
 Why?
Vaccination
1
2003
1443
0.010
 Why?
Pregnancy
1
2004
7274
0.010
 Why?
Yu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (257) concept(s)
_
Co-Authors Expand Description
See all (38) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)